PulteGroup, Inc. vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? PulteGroup, Inc. trades at $112.04 (market cap $21.63B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.88 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is the larger of the two by market cap, and Royalty Pharma plc Class A Ordinary Shares pays the higher dividend (1.66%). Which is the better fit depends on your goals — on Pluang, investors hold PulteGroup, Inc. for 91 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| PHM | RPRX | |
|---|---|---|
Market Cap | $21.63B | $25.27B |
Volume | 2,324,729 | 3,671,183 |
Sector | Consumer Cyclical | Health |
52-Week High | $142.56 | $63.96 |
52-Week Low | $110.11 | $35.44 |
Typical Hold Time | 91 Days | 1 Days |
Enterprise Value | $22.04B | $32.50B |
Dividend Yield | 0.92% | 1.66% |
Signals from Pluang's Aura AI — not financial advice
PulteGroup (PHM) trades at $112.12, down 0.19% with a bearish technical outlook. The stock shows mixed fundamentals with recent earnings misses but maintains solid profitability margins. Analyst consensus remains positive with a $139.80 price target, though technical indicators signal selling pressure amid rising mortgage rate concerns affecting the housing sector.
PHM presents value opportunity with attractive P/E of 11.6 and strong cash flow generation, but faces headwinds from rising interest rates impacting housing demand. The stock trades near support at $110 with institutional accumulation providing downside cushion, though sector volatility requires careful risk management.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
PulteGroup Inc is one of the largest homebuilders in the United States, operating in 40 markets across 23 states. The company mainly builds single-family detached homes (85% of unit sales) and offers products to entry-level, move-up, and active-adult buyers. PulteGroup offers homebuyers mortgage financing and title agency services through its financial services segment. The company is headquartered in Atlanta.
Read more on PHM →Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →